Table 1. Baseline characteristics of the patients.
| Variables | Liraglutide | Exenatide | P |
|---|---|---|---|
| Baseline age (year) | 49.6±12.5 | 54.1±9.5 | NS |
| Disease course (year) | 7.8±6.4 | 12.8±8.2 | <0.05 |
| Ratio of man (%) | 55.1 | 59.3 | NS |
| Smoking (%) | 29.5 | 40.1 | <0.05 |
| HbA1c (%) | 8.63±1.5 | 8.66±0.8 | NS |
| BMI (kg/m2) | 30.33±3.9 | 30.40±8.6 | NS |
| Systolic pressure (mmHg) | 135.30±17 | 135.00±15 | NS |
| Total cholesterol (mmol·L-1) | 5.0±1.1 | 4.1±0.6 | NS |
| High density lipoprotein (mmol·L-1) | 1.0±0.2 | 1.2±0.4 | NS |
| Low density lipoprotein (mmol·L-1) | 3.1±0.9 | 2.9±1.1 | NS |
| Triglyceride (mmol·L-1) | 3.0±2.2 | 2.8±1.9 | NS |
Data are expressed as mean ± SD. NS: no significant difference